<DOC>
	<DOCNO>NCT01241526</DOCNO>
	<brief_summary>The goal study evaluate Home-Based Disease Management program specifically develop patient Gold III/IV COPD . By improve disease knowledge , awareness significant clinical deterioration self-management skill patient , Home-Based COPD Management Program expect reduce severity exacerbation , need emergency hospitalisation , thus demonstrate efficacy cost effectiveness intervention .</brief_summary>
	<brief_title>The COPD Patient Management European Trial ( COMET )</brief_title>
	<detailed_description>Primary objective : To evaluate strategy Chronic Obstructive Pulmonary Disease ( COPD ) management reduce number hospital day patient severe Gold III/IV COPD : Home-Based COPD Management Program versus usual patient education follow-up . Secondary objective : - To assess clinical outcome health-related quality life , - To assess safety , - To evaluate medico-economic impact .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Confirmed Gold III/IV COPD Current exsmoker smoke history â‰¥ 10 packyears At least one COPD exacerbation lead hospitalization year selection . LTOT another reason COPD Severe concomitant disorder associate limited probability survival ( &lt; 6 month ) Tracheostomy Long term oral corticosteroid therapy</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>COMET</keyword>
	<keyword>Disease management</keyword>
</DOC>